Home/Filings/4/0001181431-14-004323
4//SEC Filing

ORGANOVO HOLDINGS, INC. 4

Accession 0001181431-14-004323

$VIVSCIK 0001497253operating

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 8:31 PM ET

Size

14.2 KB

Accession

0001181431-14-004323

Insider Transaction Report

Form 4
Period: 2014-01-27
Renard Michael
EVP of Commercial Operations
Transactions
  • Sale

    Common Stock

    2014-01-27$8.92/sh10,000$89,2000 total
  • Exercise/Conversion

    Common Stock

    2014-01-29$1.65/sh+30,000$49,50030,000 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2014-01-2710,000590,000 total
    Exercise: $1.65Exp: 2022-07-23Common Stock (10,000 underlying)
  • Exercise/Conversion

    Common Stock

    2014-01-27$1.65/sh+10,000$16,50010,000 total
  • Sale

    Common Stock

    2014-01-29$9.93/sh30,000$297,9990 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2014-01-2930,000560,000 total
    Exercise: $1.65Exp: 2022-07-23Common Stock (30,000 underlying)
Footnotes (5)
  • [F1]The sale of shares was effecutated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  • [F2]This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $8.90 to $8.95. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • [F3]This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $9.80 to $10.00. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • [F4]This number does not include 660,000 shares of common stock underlying outstanding options held by Mr. Renard; post-transaction Mr. Renard continues to beneficially own or have a right to acquire 660,000 shares of common stock.
  • [F5]25% of the option shares vest and become exercisable on April 30, 2013 and the remaining shares vest in 12 equal quarterly installments thereafter.

Documents

1 file

Issuer

ORGANOVO HOLDINGS, INC.

CIK 0001497253

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001497253

Filing Metadata

Form type
4
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 8:31 PM ET
Size
14.2 KB